Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-01-05 @ 5:36 PM
Study NCT ID:
NCT07177092
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-16
First Post:
2025-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
Sponsor:
Jianxing He
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-06
First Submit QC Date:
None
Study First Post Date:
2025-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED